rs146278697
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_014000.3(VCL):c.1237G>A(p.Ala413Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000575 in 1,614,160 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A413V) has been classified as Uncertain significance.
Frequency
Consequence
NM_014000.3 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathy 1WInheritance: AD Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- dilated cardiomyopathyInheritance: AD Classification: MODERATE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathy 15Inheritance: AD Classification: LIMITED Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- hypertrophic cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VCL | ENST00000211998.10 | c.1237G>A | p.Ala413Thr | missense_variant | Exon 10 of 22 | 1 | NM_014000.3 | ENSP00000211998.5 |
Frequencies
GnomAD3 genomes AF: 0.000421 AC: 64AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000298 AC: 75AN: 251402 AF XY: 0.000302 show subpopulations
GnomAD4 exome AF: 0.000591 AC: 864AN: 1461866Hom.: 2 Cov.: 31 AF XY: 0.000571 AC XY: 415AN XY: 727230 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000420 AC: 64AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000403 AC XY: 30AN XY: 74464 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
This variant is associated with the following publications: (PMID: 30847666, 26406308, 28750076, 28771489, 28087426, 24503780, 23861362)
not specified Benign:1
p.Ala413Thr in exon 10 of VCL: This variant is not expected to have clinical sig nificance due to a lack of conservation across species, including mammals. Of no te, 5 mammals (Guinea pig, ferret, shrew, tenrec, and Tasmanian devil) and 4 oth er evolutionary distinct species have a threonine (Thr) at this position despite high nearby amino acid conservation. This variant has been identified in 26/676 94 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs146278697).
Cardiomyopathy Benign:1
Dilated cardiomyopathy 1W Benign:1
Dilated cardiomyopathy 1W;C2750459:Hypertrophic cardiomyopathy 15 Benign:1
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at